Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle
NCT ID: NCT02873793
Last Updated: 2016-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
15 participants
OBSERVATIONAL
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours
NCT03262207
Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans
NCT02171845
Efficiency of Comprehensive Chromosomal Testing of Trophectoderm Biopsies of Blastocysts in In Vitro Fertilization
NCT04758819
The Effectiveness of Blastocentesis Versus Trophectoderm Biopsy
NCT02915276
The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies
NCT03062969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
7/8 cases pure seminomas
Extraction of total RNA from healthy and tumour tissues
5 cases of non-seminoma
Extraction of total RNA from healthy and tumour tissues
3 cases of composite tumours seminoma/non-seminoma.
Extraction of total RNA from healthy and tumour tissues
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extraction of total RNA from healthy and tumour tissues
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men with germinal testicular cancer with negative or low serum markers (Alpha Foeto Protein AFP and Human Chorionic Gonadotrophin hCG), indicators of a seminomatous-type tumour
* men who have undergone orchiectomy (total excision of the affected testicle)
* confirmation of the diagnosis of seminomatous or non-seminomatous type by histology of the surgical piece
* absence of hepatitis B or C or infection with human immunodeficiency virus (HIV).
Exclusion Criteria
* Adults under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAUQUE 2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.